Opinion
Video
Author(s):
The panel discusses strategies for monitoring patients with non–muscle invasive bladder cancer and the potential role of biomarkers.
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
Dr. Schwen on focal therapies for prostate cancer
Durvalumab plus BCG significantly improves DFS in NMIBC
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
FDA to host advisory committee meeting on UGN-102 for NMIBC
FDA issues refusal to file letter on sBLA for nogapendekin alfa inbakicept